The 2024-25 Merck Analyte Quarterly Update is Here!
Beyond Biomarkers!
Expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker projects.
22Nov
News
12Nov
Merck – MILLIPLEX PLEXpedition 115-Plex Screening Panel
COMPELLING PLEXABILITY
This panel enables the identification of relative changes in protein expression and is provided in a matrix-free format, allowing for analyte detection in various sample types.
08Apr
The 2023-24 Merck Analyte Quarterly Update is Here!
Products are for professional/laboratory use only.
Beyond Biomarkers!
Expect reliable measurements, a simplified user experience, and knowledgeable scientific partners to help drive your biomarker projects.
07Feb
The 2023 Merck Analyte Quarterly Update is Here!
Products are for professional/laboratory use only.
20Jun
Multiplex paving the gap between Immunology and Cell Signaling
Products are for professional/laboratory use only.
Inflammation is linked to cardiovascular disease, cancer, neurodegeneration, and other diseases.
22Apr
Expanding Possibilities in Animal Health
Products are for professional/laboratory use only.
Multiplex assays simplified the discovery and understanding of complex biological systems and processes in veterinary medicine, animal health, animal models, and human health.
06Jan
The latest Analyte Quarterly update is here!
Products are for professional/laboratory use only. With a comprehensive list of new Single Molecule Counting (SMC™), ELISA and SARS-CoV-2 kits, along with new instruments and xMAP® INTELLIFLEX Calibration and verification kits for RUO.
20Aug
SMCxPro Grant Accelerator Package
If you are looking to detect low-abundant proteins at the femtogram/mL level with the sensitivity and speed? The SMCxPRO™ immunoassay system is ideal to move your research to new levels.
01Sep
The latest 2021 Analyte Quarterly update is here!
With a comprehensive list of Merck MILLIPLEX, Single Molecule Counting (SMC) and ELISA immunoassays, including new Multiplex kits for COVID-19 research, human, high sensitivity and animal species panels.